Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Topoisomerase II alpha Protein (AA 1354-1473)

This Recombinant Topoisomerase II alpha protein is expressed in Escherichia coli (E. coli).
Catalog No. ABIN7013599

Quick Overview for Topoisomerase II alpha Protein (AA 1354-1473) (ABIN7013599)

Target

See all Topoisomerase II alpha (TOP2A) Proteins
Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Protein Type

Recombinant

Origin

  • 5
  • 2
  • 1
Human

Source

  • 3
  • 2
  • 1
Escherichia coli (E. coli)

Purity

>90 % as determined by SDS-PAGE.
  • Protein Characteristics

    AA 1354-1473

    Sequence

    AA 1354-1473

    Characteristics

    Cynomolgus TRAIL R2 / DR5 / TNFRSF10B Protein, His Tag (MALS verified)

    Endotoxin Level

    Less than 1.0 EU per μg by the LAL method.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!
    Product
    Expression System
    Conjugate
    Origin
    Price starts at
    Expression System HEK-293 Cells
    Conjugate His tag
    Origin Human
    Price starts at $13,686.36

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    50 mM Tris, 0.5 M KCl, pH 8.0

    Storage

    -80 °C
  • Target

    Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

    Alternative Name

    TOP2A

    Background

    DNA topoisomerase 2-alpha (TOP2A) is also known as DNA topoisomerase II, alpha isozyme and TOP2. It is a topoisomerase which control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks. Essential during mitosis and meiosis for proper segregation of daughter chromosomes. May play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation. Also it is the targets of anti-cancer drugs that cause treatment-related leukemias with balanced translocations.

    Molecular Weight

    12.8 kDa

    NCBI Accession

    NP_001058

    Pathways

    Cell Division Cycle, Mitotic G1-G1/S Phases
You are here:
Chat with us!